Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederinvestors.blackdiamondtherapeutics.com
Black Diamond Therapeutics, Inc. News Releases
Get the latest updates from Black Diamond Therapeutics, Inc. News Releases directly as they happen.
Follow now 36 followers
Latest posts
Last updated 10 days ago
Black Diamond Therapeutics Announces Preliminary Phase 2 Data for Silevertinib in 1L NSCLC and Plans for a Phase 2 Trial of Silevertinib in GBM
10 days ago
Silevertinib delivers robust anti-tumor activity as demonstrated by an ORR of 60%...
Black Diamond Therapeutics to Host Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update
10 days ago
Webcast to be held Wednesday, December 3, at 8:00am ET CAMBRIDGE, Mass...
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
about 1 month ago
CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc...
Black Diamond Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
about 1 month ago
ORR and preliminary duration of treatment data for the Phase 2 trial...
Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
4 months ago
Enrollment completed for the Phase 2 trial of silevertinib (BDTX-1535) in 1L...
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
7 months ago
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc...
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
7 months ago
Clinical data on track for Q4 2025 from Phase 2 trial of...
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
9 months ago
CAMBRIDGE, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc...
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
9 months ago
The partnership underscores Servier’s commitment to developing targeted therapies that address unmet...
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
9 months ago
Clinical data on track for Q2 2025 in Phase 2 trial of...
Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
about 1 year ago
Announced encouraging initial Phase 2 data of BDTX-1535 in patients with recurrent...
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
about 1 year ago
CAMBRIDGE, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc...